GE HealthCare Technologies Inc.GEHCNASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Revenue (LTM)

$20.6B

+4.8% YoY

Net Income (LTM)

$2.1B

+4.6% YoY

Free Cash Flow

$1.5B

Revenue CAGR (5Y)

+3.7%

—Marginsstable

FCF$1.5B

Profitable

Watch on earnings:Organic revenue growth by segment (Imaging, Patient Care Solutions, Pharma Diagnostics) - consensus expectations typically 4-6%Equipment orders and backlog trends - leading indicator for future revenue, particularly large imaging system dealsService revenue growth and margin profile - demonstrates installed base monetization and pricing powerAdjusted operating margin and incremental margin performance - path to 15%+ targetFree cash flow and working capital efficiency - DSO trends in equipment business

Key metrics:U.S. hospital capital spending trends and admission rates - leading indicator for imaging equipment demand · China healthcare infrastructure investment and medical device approval pipeline - drives 15-20% of revenue · Global CT and MRI procedure volume growth - directly impacts pharmaceutical diagnostics consumables demand · Service contract renewal rates and pricing - indicates installed base monetization strength

Income Statement

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	17,585	18,341↑4.3%	19,552↑6.6%	19,672↑0.6%	20,625↑4.8%
Gross Profit	7,174	7,179↑0.1%	7,922↑10.3%	8,205↑3.6%	8,247↑0.5%
Operating Income	2,795	2,522↓9.8%	2,435↓3.4%	2,625↑7.8%	2,762↑5.2%
Net Income	2,247	1,916↓14.7%	1,568↓18.2%	1,993↑27.1%	2,084↑4.6%
EBITDA	3,540	3,165↓10.6%	3,513↑11.0%	3,666↑4.4%	3,785↑3.2%
EPS Diluted	4.90	4.22↓13.9%	3.02↓28.4%	4.34↑43.7%	4.55↑4.8%

Balance Sheet

⚠ Spin-related debt burden - $3.5B debt from GE separation creates 0.96x D/E ratio, limiting financial flexibility for M&A and requiring $1.8-2.0B annual FCF for deleveraging targets

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	556	1,445↑159.9%	2,504↑73.3%	2,890↑15.4%	4,512↑56.1%
Total Current Assets	6,543	7,819↑19.5%	9,010↑15.2%	9,516↑5.6%	10,701↑12.5%
Total Assets	26,308	27,539↑4.7%	32,454↑17.8%	33,089↑2.0%	36,906↑11.5%
Total Current Liabilities	6,761	7,191↑6.4%	8,981↑24.9%	9,553↑6.4%	9,105↓4.7%
Total Liabilities	9,412	17,947↑90.7%	25,144↑40.1%	24,436↓2.8%	26,307↑7.7%
Total Equity	16,655	9,357↓43.8%	7,133↓23.8%	8,447↑18.4%	10,379↑22.9%
Total Debt	437	8,635↑1876.0%	9,863↑14.2%	9,376↓4.9%	10,003↑6.7%
Net Debt	-119	7,190↑6142.0%	7,359↑2.4%	6,486↓11.9%	5,491↓15.3%

Cash Flow Statement

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	1,607	2,113↑31.5%	2,101↓0.6%	1,951↓7.1%	1,988↑1.9%
Capital Expenditure	-248	-310↓25.0%	-387↓24.8%	-401↓3.6%	-482↓20.2%
Free Cash Flow	1,359	1,803↑32.7%	1,714↓4.9%	1,550↓9.6%	1,506↓2.8%
Stock-Based Comp	76	67↓11.8%	114↑70.1%	125↑9.6%	130↑4.0%
Net Change in Cash	-451	890↑297.3%	1,055↑18.5%	387↓63.3%	1,622↑319.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance